Mirati Therapeutics reported $56K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Astellas Pharma 4503:JP Y 103001M 0M
AstraZeneca AZN:LN 387M 0M
Bayer BAYN:GR € 2515M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Eisai 4523:JP Y 44986M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Exelixis EXEL:US $ 0.32M 0M
GlaxoSmithKline GSK:LN 1347M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Moderna Inc MRNA:US 39.2K 800
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NOVN:VX SF 890M 11M
Puma Biotechnology PBYI:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Spectrum Pharmaceuticals SPPI:US $ 0.18M 0.01M
Takeda 4502:JP Y 1676277M 14M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
YTE INCY:US $ 0.22M 0M